Rani Therapeutics' CEO, Talat Imran, and CFO, Svai Sanford, discussed the company's 2024 financial results and updates in a conference call. Rani's RaniPill technology aims to revolutionize oral biologic delivery, focusing on obesity and immunology treatments.